The current health crisis has highlighted the resilience that Belgian companies have shown to accelerate research and allow the development, in record time, of multiple therapeutic solutions to counter the Covid-19 pandemic. This social responsibility is the proof of the value that an innovative biopharmaceutical industry could bring with its expertise in dealing with an epidemic.[…]